First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - PHARMA SOLUTIONS LIMITED

ANALYSIS
Credit Risk Update: PHARMA SOLUTIONS LIMITED, C/O AZETS BURNHAM YARD, LONDON END, BEACONSFIELD, BUCKS, HP9 2JH. The legal status is a Private Limited Company and the current status at the registry of companies is Active - Proposal to Strike off. The last filed accounts are dated 31 December 2023. The company was incorporated on 9 December 1998.

The accounts next due date is 30 September 2025. There are no mortgages.

The above was based on public record information as at 22 October 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 03681208
Date Incorporated: 9 December 1998
Date Latest Accounts: 31 December 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 03681208
Annual Return: 8 December 2015
Registered Office: C/O AZETS BURNHAM YARD, LONDON END, BEACONSFIELD, BUCKS, HP9 2JH
SIC Code and Operations: 82990
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

PHARMA SOLUTIONS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 1 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
09872397 PHARMA SOLUTIONS SERVICES LIMITED Dissolved
15002025 PHARMA SOLUTIONS SERVICES UK LTD Active
14437002 PHARMA SOLVED LTD Active
07682563 PHARMA SOURCING LTD Active - Proposal to Strike off
12787398 PHARMA SPEED LTD Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd